Mortality from coronary heart disease and all causes in hypertensive participants in the multiple risk factor intervention trial after 10.5 years of follow up
Mult, R.sk Fac, I.tervention Trial, R.s Group (Usa)
Journal of Hypertension 6(Suppl 4): S752
1988
ISSN/ISBN: 0263-6352
DOI: 10.1097/00004872-198812040-00355
Accession: 028749330
PDF emailed within 0-6 h: $19.90
Related References
1990: Mortality after 10 1/2 years for hypertensive participants in the Multiple Risk Factor Intervention Trial Circulation 82(5): 1616-1628Rautaharju, P.M.; Neaton, J.D. 1987: Electrocardiographic abnormalities and coronary heart disease mortality among hypertensive men in the Multiple Risk Factor Intervention Trial Clinical and Investigative Medicine. Medecine Clinique et Experimentale 10(6): 606-615
1990: Mortality rates after 10.5 years for participants in the Multiple Risk Factor Intervention Trial. Findings related to a priori hypotheses of the trial. The Multiple Risk Factor Intervention Trial Research Group JAMA 263(13): 1795-1801
Törmä, H.; Vahlquist, A. 1986: Uptake of vitamin a and retinol-binding protein by human placenta in vitro Placenta 7(4): 295-305
Francis, G.S. 1985: Neurohumoral mechanisms involved in congestive heart failure American Journal of Cardiology 55(2): 15a-21a
Rautaharju, P.M.; Prineas, R.J.; Crow, R.S.; Neaton, J.D.; Stamler, J.; Furberg, C.D. 1984: Exercise electrocardiogram and the effectiveness of intervention on coronary heart disease mortality in the multiple risk factor intervention trial American Heart Association Monograph 107: II-60
1996: Mortality after 16 years for participants randomized to the Multiple Risk Factor Intervention Trial Circulation 94(5): 946-951
Shaten, B.J.; Kuller, L.H.; Kjelsberg, M.O.; Stamler, J.; Ockene, J.K.; Cutler, J.A.; Cohen, J.D. 1997: Lung cancer mortality after 16 years in MRFIT participants in intervention and usual-care groups. Multiple Risk Factor Intervention Trial Annals of Epidemiology 7(2): 125-136
Cohen, J.D.; Prineas, R.J.; Zhi, X.; Eberly, L.E.; Kuller, L.H.; Neaton, J.D. 2004: The impact of prior myocardial infarction, metabolic syndrome, and high white blood cell count on coronary heart disease mortality The multiple risk factor intervention trial 18-year follow-up experience Journal of the American College of Cardiology 43(5 Suppl A): 416A
Okin, P.M.; Grandits, G.; Rautaharju, P.M.; Prineas, D.J.; Cohen, J.D.; Crow, R.S.; Kligfield, P. 1995: Simple heart rate adjustment of ST depression during exercise testing in the multiple risk factor intervention trial Identification of men with decreased seven-year coronary heart disease mortality after a risk factor reduction program Circulation 92(8): I272
Multiple-Risk-Factor-Intervention-Trial-Res-Group-(Usa) 1990: Mortality rates after 10.5 years for participants in the multiple risk factor intervention trial findings related to a priori hypotheses of the trial Journal of the American Medical Association 263(13): 1795-1801
M, 1985: Exercise electrocardiogram and coronary heart disease mortality in the multiple risk factor intervention trial The American Journal of Cardiology 55(1): 16-24
Anderson, G.H. 1986: Altered neurotransmitter metabolism and availability of precursor amino acids in obesity American Journal of Clinical Nutrition 44(1): 158-159
Kannel, W.B.; Neaton, J.D.; Wentworth, D.; Thomas, H.E.; Stamler, J.; Hulley, S.B.; Kjelsberg, M.O. 1986: Overall and coronary heart disease mortality rates in relation to major risk factors in 325,348 men screened for the MRFIT. Multiple Risk Factor Intervention Trial American Heart Journal 112(4): 825-836
Cutler, J.A.; Neaton, J.D.; Hulley, S.B.; Kuller, L.; Paul, O.; Stamler, J. 1985: Coronary heart disease and all-causes mortality in the Multiple Risk Factor Intervention Trial: subgroup findings and comparisons with other trials Preventive Medicine 14(3): 293-311